CIBC Private Wealth Group
RCKT icon

CIBC Private Wealth Group’s Rocket Pharmaceuticals RCKT Stock Holding History

CIBC Private Wealth Group’s Portfolio RCKT Stock Details RCKT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-250
Closed -$5K – 1544
2018
Q2 		$5K Hold
250
– – ﹤0.01% 1726
2018
Q1 		$5K Hold
250
– – ﹤0.01% 1670
2017
Q4 		$3K Buy
+250
New +$2.48K ﹤0.01% 1780

Other funds holding RCKT

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
BM
Bridger Management New York $150M AUM 17.71% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

CIBC Private Wealth Group's RCKT Position: Q3 2018 in Review

CIBC Private Wealth Group sold out of Rocket Pharmaceuticals (RCKT) in Q3 2018, closing a stake of 250 shares — an estimated $5K sold.

CIBC Private Wealth Group first reported a position in RCKT in Q4 2017 and held it in 3 quarters. The position peaked at $5K in Q2 2018. 84 funds tracked by Wall St. Rank hold RCKT as of Q3 2018.

  • CIBC Private Wealth Group reported no remaining Rocket Pharmaceuticals position as of Q3 2018 after selling out during the quarter.
  • CIBC Private Wealth Group sold 250 Rocket Pharmaceuticals shares in Q3 2018, an estimated $5K.
  • CIBC Private Wealth Group first reported a position in Rocket Pharmaceuticals in Q4 2017 and held it in 3 quarters.
  • CIBC Private Wealth Group's Rocket Pharmaceuticals position peaked at $5K in Q2 2018.
  • 84 funds tracked by Wall St. Rank held Rocket Pharmaceuticals as of Q3 2018.

Based on CIBC Private Wealth Group's 13F filing for Q3 2018, filed 14 Nov 2018.